Development of Multifunctional Commercial Pure Titanium-Polyethylene Glycol Drug-Eluting Substrates with Enhanced Optical and Antithrombotic Properties

[61] Cowen CJ(2006)Impact on the thrombogenicity of surface oxide propertiesof 316l stainless steel for biomedical applications Spectrochim. Acta A Mol. Biomol. Spectrosc. 65 1266-undefined

[62] Quast JP(2013)Spectrometric identification of organic compounds Adv. Powder Technol. 24 125-undefined

[63] Akahori T(2000)Influence of surface pretreatment on the coating quantity and properties of nanostructured octacalcium phosphate on commercially pure titanium J. Biomech. 33 e2147-undefined

[64] Niiomi M(2019)Bioactivity enhancement of commercial pure titanium by chemical treatments Langmuir 35 230-undefined

[65] Bridgeman JT(2002)Beyond poly(ethylene glycol): linear polyglycerol as amultifunctional polyether for biomedical and pharmaceutical applications Mater. Sci. Eng. 20 131-undefined

[66] Marker VA(2018) hemocompatibility and corrosion behavior of new Zr-binary alloys in whole human blood EuroIntervention 13 91-undefined

[67] Hummel SK(2015)Polymeric systems for controlled drug release Hua Xi Kou Qiang Yi Xue Za Zhi 33 338-undefined

[68] Benson BW(2010)A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day) Sci. Technol. Adv. Mater. 11 undefined-undefined

[69] Pace LL(2014)Vibrational spectroscopic studies and ab initio calculations of sulfanilamide J. Interv. Cardiol. 27 undefined-undefined

[70] Buecker A(2016)Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery Mol. Med. Rep. 13 undefined-undefined

[61] Cowen CJ(2006)Impact on the thrombogenicity of surface oxide propertiesof 316l stainless steel for biomedical applications Spectrochim. Acta A Mol. Biomol. Spectrosc. 65 1266-undefined

[62] Quast JP(2013)Spectrometric identification of organic compounds Adv. Powder Technol. 24 125-undefined

[63] Akahori T(2000)Influence of surface pretreatment on the coating quantity and properties of nanostructured octacalcium phosphate on commercially pure titanium J. Biomech. 33 e2147-undefined

[64] Niiomi M(2019)Bioactivity enhancement of commercial pure titanium by chemical treatments Langmuir 35 230-undefined

[65] Bridgeman JT(2002)Beyond poly(ethylene glycol): linear polyglycerol as amultifunctional polyether for biomedical and pharmaceutical applications Mater. Sci. Eng. 20 131-undefined

[66] Marker VA(2018) hemocompatibility and corrosion behavior of new Zr-binary alloys in whole human blood EuroIntervention 13 91-undefined

[67] Hummel SK(2015)Polymeric systems for controlled drug release Hua Xi Kou Qiang Yi Xue Za Zhi 33 338-undefined

[68] Benson BW(2010)A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day) Sci. Technol. Adv. Mater. 11 undefined-undefined

[69] Pace LL(2014)Vibrational spectroscopic studies and ab initio calculations of sulfanilamide J. Interv. Cardiol. 27 undefined-undefined

[70] Buecker A(2016)Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery Mol. Med. Rep. 13 undefined-undefined